Search

Your search keyword '"Orbach, Daniel"' showing total 1,138 results

Search Constraints

Start Over You searched for: Author "Orbach, Daniel" Remove constraint Author: "Orbach, Daniel"
1,138 results on '"Orbach, Daniel"'

Search Results

1. Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee

3. Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC

4. Focus on melanotic neuroectodermal tumor of infancy

5. A virtual consultation system for very rare tumors in children and adolescents – an initiative of the European Cooperative Study Group in Rare Tumors in Children (EXPeRT)

6. Olfactory neuroblastoma in children and adolescents: The EXPeRT recommendations for diagnosis and management

7. Alveolar soft part sarcomas in young patients: The French national NETSARC+ network experience

8. Solutions for optimal care and research for children and adolescents with extremely rare cancers developed within the Joint Action for Rare Cancers (JARC)

9. Salivary gland carcinomas in children and adolescents: A retrospective analysis of the European Cooperative Study Group for Pediatric Rare Tumours (EXPeRT)

10. Leiomyosarcoma and liposarcoma in young patients: The national netsarc+ network experience

12. The role of cancer predisposition syndrome in children and adolescents with very rare tumours

13. Outcomes in lung-only metastatic rhabdomyosarcoma: An analysis of data from the European paediatric Soft tissue sarcoma Study Group MTS 2008 study

16. Nasopharyngeal Carcinoma

17. Thymoma and Thymic Carcinoma in Children and Adolescents

18. National Initiatives in Europe

20. Risk factors in pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST): Results from the French Pediatric Oncology Society (SFCE) cohort

21. Desmoid type fibromatosis in pediatric and young adults from French databases: Clinical characteristics and initial outcome according to age

22. Impact of age on survival according to molecular tumor findings in children and adolescents with soft-tissue and bone sarcoma: The BIOSCA project

23. Que retenir dans la prise en charge des cancers en 2022 ?

24. Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

25. Treatment at relapse for synovial sarcoma of children and adolescents: A multi‐institutional European retrospective analysis

27. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials

28. Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of International Cooperation for Highly Specialized Treatments

29. NUT carcinoma in children, adolescents and young adults

30. Locally aggressive rarely metastazing tumors and low-grade sarcoma in children, adolescents and young adults: The benefits of a national network

31. Varicella post-exposure management for pediatric oncology patients

32. Robotic Surgery in Pediatric Oncology: Lessons Learned from the First 100 Tumors—A Nationwide Experience

36. Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.

38. Tumors of the Ovary

39. The Impact of Radiation Therapy in Children and Adolescents With Metastatic Rhabdomyosarcoma

41. Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord‐stromal tumors. Results of the TGM13 National Registry

42. Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript

43. Qu’est-ce que 2023 aura permis de changer dans nos pratiques en cancérologie ?

44. New Born and Infant Soft Tissue Sarcomas

47. Head and neck tumors in children and adolescents: Impact of a multidisciplinary tumor board

48. Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network

49. Que retenir de l’année 2020 ?

50. Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group

Catalog

Books, media, physical & digital resources